Injectable Verapamil Hydrochloride Recalled Due to Cross Contamination Risk
Zydus Pharmaceuticals is recalling Verapamil Hydrochloride Injection vials nationwide due to potential cross contamination with other products.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class III FDA recall for low-risk contamination without reported illnesses or injuries. Per the rubric, precautionary recalls without confirmed harm are classified as Moderate.
Plain-English summary
Zydus Pharmaceuticals (USA) Inc. is recalling Verapamil Hydrochloride Injection, USP 5 mg/2 mL (2.5 mg/mL), a calcium channel blocker medication administered intravenously, due to potential cross contamination with other products. Approximately 170,755 single-dose vials are affected, distributed nationwide in the United States.
The recalled product is identified by the following lot numbers and expiration dates: (a) Lots L300255 and L300262, expiring 07/31/2025; (b) Lot L300263, expiring 08/31/2025. The product is manufactured by Zydus Lifesciences Ltd. in Vadodara, India, and distributed by Zydus Pharmaceuticals (USA) Inc. in Pennington, New Jersey.
The Food and Drug Administration classified this recall as Class III.
The recalled product
- Product
- VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE)
- Brand
- VERAPAMIL HYDROCHLORIDE
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Category
- Drug — Injectable
- Hazard
- Affected units
- 170,755
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot# (a) Lots L300255
- L300262
- Exp Date 07/31/2025
- (b)L300263
- Exp Date 08/31/2025
UPCs (2)
- 0370710164379
- 0370710164355
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Zydus Pharmaceuticals (USA) Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · VERAPAMIL HYDROCHLORIDE
- ModerateFDA recalls Verapamil Hydrochloride injectable due to cross contamination
FDA (Drugs) · 2024-07-17
- ModerateCardinal Health Recalls Verapamil Hydrochloride Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · Zydus Pharmaceuticals (USA) Inc
See all →- SevereZydus Recalls Hydrocortisone Sodium Succinate Injection for Impurity Failures
FDA (Drugs) · 2026-10-21
- SevereFDA Recalls Mirabegron Tablets Over Nitrosamine Impurity
FDA (Drugs) · 2026-08-12
- SevereErythromycin 500 mg Tablets Recalled for Impurity Above Limits
FDA (Drugs) · 2026-05-27
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- HighIcosapent ethyl capsules recalled after active ingredient oxidized inside capsule
FDA (Drugs) · 2026-03-18
Same hazard · cross contamination
See all →- HighFDA Recalls Performance Pro Nitrile Gloves Due to Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Opportunity Pro Nitrile Gloves Due to Manufacturing Defects
FDA (Devices) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
- ModerateSage Products Recalls Chlorhexidine Gluconate Cloth Due to Cross Contamination
FDA (Drugs) · 2026-09-09
- CriticalCetirizine Hydrochloride Tablets Recalled Due to Cross Contamination with Ranitidine
FDA (Drugs) · 2026-07-29
Similar recalls
- SevereZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross-Contamination Risk
FDA (Drugs) · 2019-06-26
- ModerateMicafungin injection vials recalled for cross-contamination
FDA (Drugs) · 2024-07-17
- ModerateMicafungin for Injection Recalled for Cross Contamination Risk
FDA (Drugs) · 2024-07-17
- ModerateZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross Contamination
FDA (Drugs) · 2019-06-26
- ModerateZydus Recalls Pramipexole Dihydrochloride Tablets Due to Cross-Contamination
FDA (Drugs) · 2019-06-26
- SevereChlorpromazine Hydrochloride Tablets Recalled Due to Impurity
FDA (Drugs) · 2025-04-16